ALDX stock-based compensation history

Trailing twelve months (TTM) · USD. Each value covers four complete reported quarters.

Aldeyra Therapeutics Inc Stock-Based Compensation — Trailing twelve months (TTM) (USD)
Period ending	Stock-Based Compensation (USD)
Jun 30, 2026	2,683,281
Mar 31, 2026	2,879,846
Dec 31, 2025	6,091,413
Sep 30, 2025	6,264,671
Jun 30, 2025	6,909,711
Mar 31, 2025	8,648,675
Dec 31, 2024	7,973,499
Sep 30, 2024	5,909,819
Jun 30, 2024	3,473,241
Mar 31, 2024	3,111,252
Dec 31, 2023	5,752,771
Sep 30, 2023	9,374,404
Jun 30, 2023	10,821,959
Mar 31, 2023	10,542,754
Dec 31, 2022	8,288,976
Sep 30, 2022	6,452,157
Jun 30, 2022	5,633,722
Mar 31, 2022	6,662,949
Dec 31, 2021	7,108,027
Sep 30, 2021	7,753,844
Jun 30, 2021	8,092,987
Mar 31, 2021	7,511,814
Dec 31, 2020	7,083,810
Sep 30, 2020	7,402,281
Jun 30, 2020	7,797,740
Mar 31, 2020	8,150,314
Dec 31, 2019	8,082,751
Sep 30, 2019	7,151,924
Jun 30, 2019	6,272,706
Mar 31, 2019	5,162,527
Dec 31, 2018	4,144,853
Sep 30, 2018	3,719,091
Jun 30, 2018	3,104,710
Mar 31, 2018	2,725,160
Dec 31, 2017	2,714,841
Sep 30, 2017	2,722,708
Jun 30, 2017	2,940,396
Mar 31, 2017	3,008,741
Dec 31, 2016	2,759,753
Sep 30, 2016	2,706,886
Jun 30, 2016	2,366,128
Mar 31, 2016	2,156,137
Dec 31, 2015	2,187,102
Sep 30, 2015	2,105,108
Jun 30, 2015	2,026,627
Mar 31, 2015	2,311,460
Dec 31, 2014	2,037,073
Sep 30, 2014	1,945,134
Jun 30, 2014	2,140,996
Mar 31, 2014	2,016,952
Dec 31, 2013	1,701,713
Sep 30, 2013	1,364,647